IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aqualis acquires Norwegian API producer Weifa

9:37 AM MDT | June 17, 2014 | Deepti Ramesh

Aqualis (Oslo) announced on 17 June that it has entered into a definitive share purchase agreement with Weifa Holding to acquire all of the shares in Weifa (Oslo), a leading, fully-integrated pharmaceutical company in Norway and a major supplier of active pharmaceutical ingredients (APIs) to the international pharmaceutical industry, for 1.1 billion Norwegian kroner ($184 million). Aqualis is involved in the marine and offshore and health-care businesses. Weifa is a market leader within the consumer health pain-relief segment and a leading supplier of APIs for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa